Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL25266373 | 1.00 | ALDH1A1 (0.52) | ALDH1A1NAAAATMHCAR2DGKA | |
| Ammonia Solution, Strong SCHEMBL6657318 | 0.97 | ALDH1A1 (0.48) | ALDH1A1NAAAATMHCAR2DGKA | |
| SCHEMBL25201606 | 0.95 | ALDH1A1 (0.47) | ALDH1A1NAAAATMHCAR2DGKA | |
| SCHEMBL27684479 | 0.95 | NAAA (0.50) | ALDH1A1NAAAHCAR2DGKABLM | |
| Citric Acid SCHEMBL27893856 | 0.95 | NAAA (0.50) | ALDH1A1NAAAHCAR2DGKABLM | |
| SCHEMBL1219023 | 0.95 | NAAA (0.50) | ALDH1A1NAAAHCAR2DGKABLM | |
| SCHEMBL1412785 | 0.95 | NAAA (0.47) | ALDH1A1NAAAATMHCAR2DGKA | |
| Tributyl Citrate SCHEMBL7083497 | 0.94 | ALDH1A1 (0.46) | ALDH1A1NAAAATMHCAR2DGKA | |
| SCHEMBL9410612 | 0.93 | NAAA (0.53) | ALDH1A1NAAAHCAR2DGKATSHR | |
| SCHEMBL4598009 | 0.93 | NAAA (0.53) | ALDH1A1NAAAHCAR2DGKATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 937 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197600-A1 | CITRIC ACID-GLYCIDYL ETHER-BUTYL ESTER PLASTICIZER AND PREPARATION METHOD THEREOF | BEIJING TECHNOLOGY AND BUSINESS UNIVERSITY | 2025-06-19 | — | — | US | claimed |
| US-20250137194-A1 | SYNTHETIC OR FOAMED SYNTHETIC MATERIAL COATED WITH BIO-BASED FORMULATION | LEATHEIST LLP (IN) | 2025-05-01 | — | — | US | claimed |
| US-20250000801-A1 | DAROLUTAMIDE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | SINOTHERAPEUTICS INC. (CN) | 2025-01-02 | — | — | US | claimed |
| CN-114315576-B | Preparation method of bio-based degradable plasticizer | 山东万图高分子材料股份有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-118403017-A | Strong-hydrophobicity slow-release microsphere and preparation method and application thereof | 广东药科大学 | 2024-07-30 | — | — | CN | claimed |
| CN-117736429-B | Citric acid-glycidyl ether-butyl ester plasticizer and preparation method and application thereof | 北京工商大学 | 2024-07-09 | — | — | CN | claimed |
| CN-118284415-A | Darotamine pharmaceutical composition and preparation method and application thereof | 上海宣泰医药科技股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-116066037-B | Chemical system for reducing minimum miscible pressure of CO2 flooding of low-permeability oilfield and screening method thereof | 中国石油天然气股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-117797051-A | Sun-screening composition capable of resisting water and sweat with characteristics of paste, lasting, synergistic SPF and PA values | 广州科创材料科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117736429-A | Citric acid-glycidyl ether-butyl ester plasticizer and preparation method and application thereof | 北京工商大学 | 2024-03-22 | — | — | CN | claimed |
| EP-1093356-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INTERNATIONAL B.V. (NL) | 2001-04-25 | — | — | EP | claimed |
| WO-2000001357-A1 | METHOD OF REDUCING OR PREVENTING MALODOUR | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
| WO-1997034585-A1 | TRANSPARENT HARD CAPSULES | SMITHKLINE BEECHAM PLC (GB) | 1997-09-25 | — | — | WO | claimed |
| WO-1997003642-A1 | SUNSCREEN COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1997-02-06 | — | — | WO | claimed |
| EP-0561947-A4 | — | — | 1994-01-12 | — | — | EP | claimed |
| EP-0561947-A1 | MULTIFUNCTIONAL ADDITIVES TO IMPROVE THE LOW-TEMPERATURE PROPERTIES OF DISTILLATE FUELS AND COMPOSITIONS CONTAINING SAME | MOBIL OIL CORPORATION (US) | 1993-09-29 | — | — | EP | claimed |
| WO-1992009673-A1 | MULTIFUNCTIONAL ADDITIVES TO IMPROVE THE LOW-TEMPERATURE PROPERTIES OF DISTILLATE FUELS AND COMPOSITIONS CONTAINING SAME | MOBIL OIL CORPORATION (US) | 1992-06-11 | — | — | WO | claimed |
| EP-0397245-A2 | Perfume particles for use in cleaning and conditioning compositions | THE PROCTER & GAMBLE COMPANY (US) | 1990-11-14 | — | — | EP | claimed |
| EP-0316924-A1 | Solvent composition and process employing same | SANDOZ AG (CH) | 1989-05-24 | — | — | EP | claimed |
| US-4391938-A | ESTERS | ROHM AND HAAS COMPANY (US) | 1983-07-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000801-A1 | DAROLUTAMIDE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | AR, NR5A1, HSD17B7 | ALDH1A1 954/4885NAAA 4239/4885ATM 4733/4885 |
| US-20250197600-A1 | CITRIC ACID-GLYCIDYL ETHER-BUTYL ESTER PLASTICIZER AND PREPARATION METHOD THEREOF | PGAM1, PGD, GCDH | ALDH1A1 1134/4885NAAA 690/4885ATM 3010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.